Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and Arenaviruses
Viruses, Free Full-Text
SARS-CoV-2 antibodies and their neutralizing capacity against live virus in human milk after COVID-19 infection and vaccination: prospective cohort studies - The American Journal of Clinical Nutrition
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition - ScienceDirect
Replication and Propagation of Attenuated Vesicular Stomatitis Virus Vectors In Vivo: Vector Spread Correlates with Induction of Immune Responses and Persistence of Genomic RNA
Frontiers Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner
Pathogens, Free Full-Text
Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity - ScienceDirect
Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes, (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors
High-titer manufacturing of SARS-CoV-2 Spike-pseudotyped VSV in stirred-tank bioreactors - ScienceDirect
rVSV-d-G/SARS-CoV-2-S_D614Gd21-NLucP - Kerafast
Viruses, Free Full-Text